Recently John C. Morris, MD, Director of the Knight Alzheimer Disease Research Center at Washington University in St. Louis and member of the ABF research advisory committee, said there are several reasons to have hope and optimism for the future in regards to Alzheimer’s disease. Involved in Alzheimer’s research since 1983, he explained for the first time he believes “there is now a great opportunity to develop effective therapies, including drugs currently under evaluation for treatment.” He said advances also include an important tool for diagnosing the disease.
One of the reasons for optimism was the announcement of the pharmaceutical company Biogen’s controversial new drug, which purportedly is designed to treat Alzheimer’s disease and not just the symptoms. The drug, aducanumab was approved for use on patients on June 7 2021. However doctors say it is important to know the FDA’s approval is only for the drug’s ability to reduce the amount of amyloid plaques in the brains of people given the drug. They state it is still unknown whether the removal of the plaque offers benefits to the patients. To be eligible to receive the drug, patients need to have a firm diagnosis of Alzheimer’s.
In the year 2020, we also heard the news about a ground-breaking new blood test at the Alzheimer’s Association International Conference 2020. Researchers say the new test identifies the protein ptau-2017, a biomarker for Alzheimer’s, and results have been far more accurate than several other biomarkers currently being tested. This is good news as doctors say earlier testing will lead to earlier interventions. The test received a Breakthrough Device designation by the FDA in October 2021.
At the MorningStar at Golden Ridge, we provide a range of senior living options including holistic memory care. Residents in our Reflections Neighborhood receive compassionate, expert care, amenities and meaningful activities to enhance quality of life. Please contact us regarding availability at one of the most trusted independent living, assisted living and memory care in Peoria.
Source:
americanbrainfoundation.org/research-in-dementia-2022/?gclid=Cj0KCQiAuvOPBhDXARIsAKzLQ8GeKsmbzH9wiQeieSXmQRQpWuapAPu0LIT7aQ6J6tjPcMsB35h7LHMaAmNkEALw_wcB
No comments:
Post a Comment